about
Testing for allergic disease: parameters considered and test valueUsing secondary data sources for pharmacoepidemiology and outcomes research.Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.Risk of fracture and the concomitant use of bisphosphonates with osteoporosis-inducing medications.The Choice of Analytical Strategies in Inverse-Probability-of-Treatment-Weighted Analysis: A Simulation StudyAn Epidemiological Study of Anemia and Renal Dysfunction in Patients Admitted to ICUs across the United States.Diversity of antimicrobial use and resistance in 42 hospitals in the United States.Effect of Renin-Angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndromeWarfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.The Impact of Integrated Case Management on Health Services Use and Spending Among Nonelderly Adult Medicaid Enrollees.Homeless patients' use of urban emergency departments in the United States.Increase in use of vancomycin for Clostridium difficile infection in US hospitals.Fluoroquinolone use and fluoroquinolone-resistant Pseudomonas aeruginosa is declining in US academic medical centre hospitals.Warfarin use in nursing home residents: results from the 2004 national nursing home survey.Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.The relative importance of health related quality of life and prescription insurance coverage in the decision to pharmacologically manage symptoms of overactive bladder.Trends in aminoglycoside use and gentamicin-resistant gram-negative clinical isolates in US academic medical centers: implications for antimicrobial stewardship.Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.The importance of study design when comparing baseline characteristics between study groups.Potentially inappropriate medication use is associated with clinical outcomes in critically ill elderly patients with neurological injury.Evaluation of electrolyte repletion in hematopoietic cell transplant patients receiving H-2 receptor antagonists or proton pump inhibitors.Response to "modifications to the drug burden index calculation may limit interpretation of its association with clinical outcomes in older adults"(doi:10.1007/s12028-014-0006-8).Use of antibiotics and risk of cancer.Patient preferences for objective quality metrics during community pharmacy selection: A discrete choice experimentImproving the safety of medication administration using an interactive CD-ROM programBeing open to missed opportunitiesDeveloping a Measure of Students' Potential Involvement in Scholarly ActivitiesEvaluating a measure of the research training environment in a sample of pharmacy residents
P50
Q33363457-78341B69-CC8A-4BC5-89B3-3BAA13A27C81Q33403014-F989BE4B-2A03-403B-B84F-33F29E8A1443Q33508665-9922631C-CEA4-4CD9-A1D3-7111CD27D3FCQ34462037-0D505292-675F-438B-A980-096E4F7DFABFQ36045096-1D6B4E5E-EF39-4060-B493-CBB4ACC00F1EQ36180492-9977C0BD-7889-48F8-B81E-6A0D4A8F5A17Q37199197-B2FD4C22-13E0-4585-B8B6-C14526DB1538Q37643052-7BE52396-5D6F-42A9-9496-0252CEF8D85BQ38054305-2D0A81CF-ECFF-4F63-AE57-C96E4F8FABF5Q38843118-9E2CC038-9BDF-4867-983D-56862F905918Q40241021-BB905AF5-0148-41DE-8739-97BE40203B54Q43002296-D935BE08-5EA4-4FF0-8798-2AC9B11F4A20Q43169894-DF88477A-92E1-453B-824D-173EEF880D8FQ43468261-84B9E267-8024-4B90-AEFE-EA7AD92C474EQ43992514-4F8094D0-5B7A-4AFD-AAEE-52D81AEC81A3Q44878821-89F24C98-DE9E-419D-B22D-448A7EBB853CQ44928040-A4318945-8AD3-40FF-A46E-BDC0C23DF3CAQ44933030-01050FF5-F2BF-4407-B70A-7E1727B6980AQ44975350-FA8FB2D8-AF96-48C4-BCEF-A6BB65E5B57DQ44982093-3DB6DF03-D301-45B2-943F-775A983202A7Q44983328-38AB0C16-951A-4469-9B54-7F9529C1F8DFQ44997797-C15B6261-9F9F-46B3-A067-DFC1CBB2D8E7Q44998034-C31537FE-7385-49F0-B5AF-FE0CC3FF7DD6Q45003174-070F4CBC-25BC-4C2B-83F0-C96C187A22E2Q52963783-3D07E9B2-2D5C-4A7B-8EF6-8F7C8F1903B8Q57170311-03464A1A-9E67-49DA-9590-9686A1728E92Q82063076-FF3905DE-779E-4AAD-B07D-277B7B16FD03Q86502890-0C2C6AF9-8DC2-46C1-9295-9BC553CB4C77Q89147057-BEB8BE9D-B4AC-4FD4-B27A-FA4FBE189969Q90349090-0D5BBCD8-0883-408E-A33E-4692E889AC70
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Spencer E. Harpe
@ast
Spencer E. Harpe
@en
Spencer E. Harpe
@es
Spencer E. Harpe
@nl
Spencer E. Harpe
@sl
type
label
Spencer E. Harpe
@ast
Spencer E. Harpe
@en
Spencer E. Harpe
@es
Spencer E. Harpe
@nl
Spencer E. Harpe
@sl
prefLabel
Spencer E. Harpe
@ast
Spencer E. Harpe
@en
Spencer E. Harpe
@es
Spencer E. Harpe
@nl
Spencer E. Harpe
@sl
P1053
L-6675-2013
P106
P1153
8530668900
P21
P31
P3829
P496
0000-0002-3010-0163